Estrogen-induced cholestasis is characterized by impaired hepatic uptake and biliary bile acids secretion because of changes in hepatocyte transporter expression. The induction of heme oxygenase-1 (HMOX1), the inducible isozyme in heme catabolism, is mediated via the Bach1/Nrf2 pathway, and protects livers from toxic, oxidative and inflammatory insults. However, its role in cholestasis remains unknown. Here, we investigated the effects of HMOX1 induction by heme on ethinylestradiol-induced cholestasis and possible underlying mechanisms. Wistar rats were given ethinylestradiol (5 mg/kg s.c.) for 5 days. HMOX1 was induced by heme (15 μmol/kg i.p.) 24 hrs prior to ethinylestradiol. Serum cholestatic markers, hepatocyte and renal membrane transporter expression, and biliary and urinary bile acids excretion were quantified. Ethinylestradiol significantly increased cholestatic markers (P ≤ 0.01), decreased biliary bile acid excretion (39%, P = 0.01), down-regulated hepatocyte transporters (Ntcp/Oatp1b2/Oatp1a4/Mrp2, P ≤ 0.05), and up-regulated Mrp3 (348%, P ≤ 0.05). Heme pre-treatment normalized cholestatic markers, increased biliary bile acid excretion (167%, P ≤ 0.05) and up-regulated hepatocyte transporter expression. Moreover, heme induced Mrp3 expression in control (319%, P ≤ 0.05) and ethinylestradiol-treated rats (512%, P ≤ 0.05). In primary rat hepatocytes, Nrf2 silencing completely abolished heme-induced Mrp3 expression. Additionally, heme significantly increased urinary bile acid clearance via up-regulation (Mrp2/Mrp4) or down-regulation (Mrp3) of renal transporters (P ≤ 0.05). We conclude that HMOX1 induction by heme increases hepatocyte transporter expression, subsequently stimulating bile flow in cholestasis. Also, heme stimulates hepatic Mrp3 expression via a Nrf2-dependent mechanism. Bile acids transported by Mrp3 to the plasma are highly cleared into the urine, resulting in normal plasma bile acid levels. Thus, HMOX1 induction may be a potential therapeutic strategy for the treatment of ethinylestradiol-induced cholestasis.

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Schreiber AJ, Simon FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology. 1983;3:607–13. PubMed

Lammert F, Marschall HU, Glantz A, et al. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33:1012–21. PubMed

Simon FR, Fortune J, Iwahashi M, et al. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol. 1996;271:G1043–52. PubMed

Bossard R, Stieger B, O'Neill B, et al. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest. 1993;91:2714–20. PubMed PMC

Bouchard G, Yousef IM, Tuchweber B. Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethinyl estradiol in rats. Toxicol Lett. 1994;74:221–33. PubMed

Geier A, Dietrich CG, Gerloff T, et al. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim Biophys Acta. 2003;1609:87–94. PubMed

Huang L, Smit JW, Meijer DK, et al. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats. Hepatology. 2000;32:66–72. PubMed

Geier A, Wagner M, Dietrich CG, et al. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta. 2007;1773:283–308. PubMed

Koopen NR, Post SM, Wolters H, et al. Differential effects of 17alpha-ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat. J Lipid Res. 1999;40:100–8. PubMed

Elias E, Iqbal S, Knutton S, et al. Increased tight junction permeability: a possible mechanism of oestrogen cholestasis. Eur J Clin Invest. 1983;13:383–90. PubMed

Jirkovska M, Majer F, Smidova J, et al. Changes in GM1 ganglioside content and localization in cholestatic rat liver. Glycoconj J. 2007;24:231–41. PubMed

Petr T, Smid V, Kucerova V, et al. The effect of heme oxygenase on ganglioside redistribution within hepatocytes in experimental estrogen-induced cholestasis. Physiol Res. 2014;63:359–67. PubMed

Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968;61:748–55. PubMed PMC

Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–54. PubMed

Reichard JF, Motz GT, Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res. 2007;35:7074–86. PubMed PMC

Willis D, Moore AR, Frederick R, et al. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med. 1996;2:87–90. PubMed

Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: a putative neural messenger. Science. 1993;259:381–4. PubMed

Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol. 2010;30:1634–41. PubMed PMC

Vitek L, Novotny L, Sperl M, et al. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis. 2006;21:408–14. PubMed

Abraham NG, Rezzani R, Rodella L, et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol. 2004;287:H2468–77. PubMed

Chan EC, Dusting GJ, Liu GS, et al. Redox mechanisms of the beneficial effects of heme oxygenase in hypertension. J Hypertens. 2014;32:1379–86. PubMed

Skrzypek K, Tertil M, Golda S, et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal. 2013;19:644–60. PubMed PMC

Goda N, Suzuki K, Naito M, et al. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin Invest. 1998;101:604–12. PubMed PMC

Suematsu M, Ishimura Y. The heme oxygenase-carbon monoxide system: a regulator of hepatobiliary function. Hepatology. 2000;31:3–6. PubMed

Ke B, Shen XD, Gao F, et al. Small interfering RNA targeting heme oxygenase-1 (HO-1) reinforces liver apoptosis induced by ischemia-reperfusion injury in mice: HO-1 is necessary for cytoprotection. Hum Gene Ther. 2009;20:1133–42. PubMed PMC

Lai IR, Chang KJ, Tsai HW, et al. Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. Transplantation. 2008;85:732–8. PubMed

Suematsu M, Kashiwagi S, Sano T, et al. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem Biophys Res Commun. 1994;205:1333–7. PubMed

Norimizu S, Kudo A, Kajimura M, et al. Carbon monoxide stimulates mrp2-dependent excretion of bilirubin-IXalpha into bile in the perfused rat liver. Antioxid Redox Signal. 2003;5:449–56. PubMed

Shinoda Y, Suematsu M, Wakabayashi Y, et al. Carbon monoxide as a regulator of bile canalicular contractility in cultured rat hepatocytes. Hepatology. 1998;28:286–95. PubMed

Vanova K, Suk J, Petr T, et al. Protective effects of inhaled carbon monoxide in endotoxin-induced cholestasis is dependent on its kinetics. Biochimie. 2014;97:173–80. PubMed

Chen CY, Kao CY, Lin PJ, et al. Carbon monoxide may enhance bile secretion by increasing glutathione excretion and Mrp2 expression in rats. J Chin Med Assoc. 2013;76:258–64. PubMed

Muchova L, Vanova K, Zelenka J, et al. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med. 2011;15:1156–65. PubMed PMC

Vreman HJ, Stevenson DK. Heme oxygenase activity as measured by carbon monoxide production. Anal Biochem. 1988;168:31–8. PubMed

Setchell KD, Lawson AM. Bile acids. In: Lawson AM, editor. Mass spectrometry. Berlin, New York: Walter deGruyter; 1989. pp. 55–109.

Shaik IH, Mehvar R. Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples. Anal Bioanal Chem. 2006;385:105–13. PubMed PMC

Berry MN, Edwards AM, Barritt GJ. Isolated hepatocytes: preparation, properties, and applications. New York, NY: Elsevier; 1991. pp. 1–460.

Kyokane T, Norimizu S, Taniai H, et al. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology. 2001;120:1227–40. PubMed

Zhong W, Xia Z, Hinrichs D, et al. Hemin exerts multiple protective mechanisms and attenuates dextran sulfate sodium-induced colitis. J Pediatr Gastroenterol Nutr. 2010;50:132–9. PubMed

Ndisang JF, Lane N, Syed N, et al. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology. 2010;151:549–60. PubMed

Salley TN, Mishra M, Tiwari S, et al. The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. PLoS ONE. 2013;8:e79270. PubMed PMC

Ndisang JF, Jadhav A. Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. J Card Fail. 2009;15:616–28. PubMed

Luo YP, Jiang L, Kang K, et al. Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. Int Immunopharmacol. 2014;20:24–32. PubMed

Cao J, Stieger B, Meier PJ, et al. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol. 2002;283:G757–66. PubMed

Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–26. PubMed PMC

Maher JM, Dieter MZ, Aleksunes LM, et al. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology. 2007;46:1597–610. PubMed

Okada K, Shoda J, Taguchi K, et al. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochem Biophys Res Commun. 2009;389:431–6. PubMed

Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003;83:633–71. PubMed

Lee J, Azzaroli F, Wang L, et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology. 2001;121:1473–84. PubMed

The physiology of bilirubin: health and disease equilibrium

Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis

Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats

Enzymatic methods may underestimate the total serum bile acid concentration

Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells